共 50 条
- [41] Selinexor synergizes with anti-PD-1 antibody and inhibits tumor growth and metastasis in syngeneic mouse models of KRAS mutant colorectal cancer.CANCER RESEARCH, 2022, 82 (12)Chang, HuaHenegar, LeahWalker, Christopher J.Kashyap, TrinayanMaloof, MarieWang, FengMartyn, KathleenOrr, ShiraKauffman, Michael G.Shacham, SharonLandesman, Yosef
- [42] SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer modelsCLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)Synn, Chun-BongKim, Sung EunLee, Hee KyuKim, Min-HwanKim, Jae HwanLee, Ji MinJo, Ha NiLee, WongeunKim, Dong KwonByeon, YoungseonKim, Young SeobYun, Mi RanPark, Chae-WonYun, JiyeonLim, SangbinHeo, Seong GuYang, San-DukLee, Eun JiLee, SeulChoi, HunmiLee, You WonCho, Jae SeokKim, Do HeePark, SunghoKim, Jung-HoChoi, YewonLee, Sung SookAhn, Beung-ChulKim, Chang GonLim, Sun MinHong, Min HeeKim, Hye RyunPyo, Kyoung-HoCho, Byoung Chul
- [43] PRO1184, a novel folate receptor alpha-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mouse carcinoma modelsCANCER RESEARCH, 2022, 82 (12)Zhao, BaitengWang, LeiLiu, HaidongHuang, SupingShang, XiaoHan, Tae
- [44] Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman PrimatesPHARMACEUTICALS, 2021, 14 (10)Matsumoto, HirokiWatabe, TadashiIgarashi, ChikaTachibana, TomokoHihara, FukikoWaki, AtsuoZhang, Ming-RongTashima, HideakiYamaya, TaigaOoe, KazuhiroShimosegawa, EkuHatazawa, JunYoshida, SeiNaito, KenichiroKurihara, HiroakiUeno, MakotoIto, KimiteruHigashi, TatsuyaYoshii, Yukie
- [45] Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancerCANCER RESEARCH, 2020, 80 (16)Kim, WoosookFu, NaDuddempudi, PhaneendraDubeykovskaya, ZinaidaAlmo, StevenGuha, ChandanLederman, SethWang, Timothy
- [46] [225Ac]Ac-DPI-4452, a new peptide radioligand targeting Carbonic Anhydrase IX, displays strong anti-tumoral activity in colorectal cancer and clear cell renal cell carcinoma mouse modelsEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S158 - S159Wiedemann, N.Attinger, A.Branquinho, E. Da CostaAndersson, U.
- [47] An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLCCANCER RESEARCH, 2018, 78 (13)Koopman, Louise A.Janmaat, Maarten L.Jacobsen, KirstineTerp, Mikkel GreenGresnigt-van den Heuvel, ElkeForssman, UlfLingnau, AndreasParren, Paul W.Ditzel, HenrikBreij, Esther C.
- [48] ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancerCANCER LETTERS, 2020, 473 : 156 - 163Barok, MarkLe Joncour, VadimMartins, AnaIsola, JormaSalmikangas, MarkoLaakkonen, PirjoJoensuu, Heikki
- [49] Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancerAMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (07): : 3399 - 3410Kasai, NoriyukiSasakawa, AyaHosomi, KentaPoh, Tze WeiChua, Bernadette LynnYong, Wei PengSo, JimmyChan, Shing LengSoong, RichieKono, KojiIshii, ToshihikoYamano, Kazuya
- [50] Tucatinib, a HER2-selective tyrosine kinase inhibitor, increases the anti-tumor activity of trastuzumab antibody-drug conjugates in preclinical models of HER2+breast cancerCANCER RESEARCH, 2020, 80 (04)Kulukian, AnitaTaylor, JanelleOlson, DevraZaval, MargoThurman, RobertHengel, ShawnaFarr, LaurenLewis, Tim S.Peterson, Scott R.